Cell-containing bone graft material
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 20, 2012
Grant Date -
Oct 2, 2003
app pub date -
Mar 29, 2002
filing date -
Mar 29, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
This invention relates to a musculoskeletogenic MSG graft composite made from whole bone marrow aspirate BMA having native levels of musculoskeletal progenitor cells MSPCs, comprising:
- a) a suspension of fractionated BMA comprising:i) MSPCs present at a level greater than their native level in whole BMA, andii) red blood cells RBCs present at a level less than their native level in whole BMA, andb) a porous sterile matrix having an average pore size of at least 20 μm.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully